» Articles » PMID: 28540289

Stem Cell-Induced Biobridges As Possible Tools to Aid Neuroreconstruction After CNS Injury

Overview
Specialty Cell Biology
Date 2017 May 26
PMID 28540289
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Notch-induced mesenchymal stromal cells (MSCs) mediate a distinct mechanism of repair after brain injury by forming a biobridge that facilitates biodistribution of host cells from a neurogenic niche to the area of injury. We have observed the biobridge in an area between the subventricular zone and the injured cortex using immunohistochemistry and laser capture. Cells in the biobridge express high levels of extracellular matrix metalloproteinases (MMPs), specifically MMP-9, which co-localized with a trail of MSCs graft. The transplanted stem cells then become almost undetectable, being replaced by newly recruited host cells. This stem cell-paved biobridge provides support for distal migration of host cells from the subventricular zone to the site of injury. Biobridge formation by transplanted stem cells seems to have a fundamental role in initiating endogenous repair processes. Two major stem cell-mediated repair mechanisms have been proposed thus far: direct cell replacement by transplanted grafts and bystander effects through the secretion of trophic factors including fibroblast growth factor 2 (FGF-2), epidermal growth factor (EGF), stem cell factor (SCF), erythropoietin, and brain-derived neurotrophic factor (BDNF) among others. This groundbreaking observation of biobridge formation by transplanted stem cells represents a novel mechanism for stem cell mediated brain repair. Future studies on graft-host interaction will likely establish biobridge formation as a fundamental mechanism underlying therapeutic effects of stem cells and contribute to the scientific pursuit of developing safe and efficient therapies not only for traumatic brain injury but also for other neurological disorders. The aim of this review is to hypothetically extend concepts related to the formation of biobridges in other central nervous system disorders.

Citing Articles

Constraint-Induced Movement Therapy (CIMT) and Neural Precursor Cell (NPC) Transplantation Synergistically Promote Anatomical and Functional Recovery in a Hypoxic-Ischemic Mouse Model.

Rumajogee P, Altamentova S, Li J, Puvanenthirarajah N, Wang J, Asgarihafshejani A Int J Mol Sci. 2024; 25(17).

PMID: 39273353 PMC: 11395467. DOI: 10.3390/ijms25179403.


Mesenchymal Stromal Cells in Ischemic Brain Injury.

Brooks B, Ebedes D, Usmani A, Vega Gonzales-Portillo J, Gonzales-Portillo D, Borlongan C Cells. 2022; 11(6).

PMID: 35326464 PMC: 8947674. DOI: 10.3390/cells11061013.


Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration.

Pereira P, Papy-Garcia D, Barritault D, Chiappini F, Jackisch R, Schimchowitsch S Glycoconj J. 2022; 39(1):107-130.

PMID: 35254602 PMC: 8979900. DOI: 10.1007/s10719-022-10047-x.


Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.

Toledo A, Monroy G, Esparza Salazar F, Lee J, Jain S, Yadav H Int J Mol Sci. 2022; 23(3).

PMID: 35163103 PMC: 8834995. DOI: 10.3390/ijms23031184.


Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke.

Berlet R, Anthony S, Brooks B, Wang Z, Sadanandan N, Shear A Biomolecules. 2021; 11(9).

PMID: 34572529 PMC: 8468342. DOI: 10.3390/biom11091316.


References
1.
Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M . Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One. 2013; 8(9):e74857. PMC: 3762783. DOI: 10.1371/journal.pone.0074857. View

2.
Hsieh J, Wang H, Chang S, Liao K, Lee I, Lin W . Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One. 2013; 8(8):e72604. PMC: 3749979. DOI: 10.1371/journal.pone.0072604. View

3.
Eissa A, Krass I, Bajorek B . Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). J Clin Pharm Ther. 2012; 37(6):620-9. DOI: 10.1111/j.1365-2710.2012.01366.x. View

4.
Hassani Z, OReilly J, Pearse Y, Stroemer P, Tang E, Sinden J . Human neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with stroke. PLoS One. 2012; 7(11):e50444. PMC: 3503964. DOI: 10.1371/journal.pone.0050444. View

5.
Graham G . Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003; 34(12):2847-50. DOI: 10.1161/01.STR.0000101752.23813.C3. View